And in the situation of other medication for people with weight problems who have a higher chance for cardiovascular disease, the brand name-title FDA-authorized alternative may be of extra concern compared to the compounded GLP-1 agonist. The weight problems societies recommend: "If you cannot come across or get entry to a GLP-one-centered therapy